Canary PASS: A Unique Research Partnership

The Canary Foundation is a non-profit organization dedicated to early detection of cancer. In 2007, the Canary Foundation gathered a team of leading prostate cancer researchers to identify and address the key questions in the field.

The experts designed a study to address one of the most important questions in prostate cancer research:

How to tell which seemingly low risk cancers will become aggressive and which will remain inactive?

The Canary Foundation formed a unique partnership with the National Cancer Institute’s (NCI) Early Detection Research Network (EDRN) to provide coordination and data management for the Prostate Active Surveillance Study or PASS.

PASS began enrolling participants in July 2008 at six clinical sites. PASS has since expanded to ten sites across the U.S. and Canada.

Funding for the study continues to come from multiple sources including grants from the National Institutes of Health and the Department of Defense as well as partnerships with biotechnology companies and the Canary Foundation.

         

Who can participate in PASS?

What happens to those who participate in PASS?